According to REGENXBIO's latest financial reports the company has C$0.37 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $C$0.37 B | -9.89% |
2023-12-31 | $C$0.41 B | -40.97% |
2022-12-31 | $C$0.70 B | -28.09% |
2021-12-31 | $C$0.97 B | 102.23% |
2020-12-31 | $C$0.48 B | -18.08% |
2019-12-31 | $C$0.58 B | -15.17% |
2018-12-31 | $C$0.69 B | 201.22% |
2017-12-31 | $C$0.23 B | 5.87% |
2016-12-31 | $C$0.21 B | -27.73% |
2015-12-31 | $C$0.30 B | -4648.35% |
2014-12-31 | $-C$6.62 Million | 189.86% |
2013-12-31 | $-C$2.29 Million |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | C$0.30 B | -19.86% | ๐บ๐ธ USA |